These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19205699)

  • 1. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
    Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
    Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
    Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
    Hanamoto A; Takenaka Y; Shimosegawa E; Ymamamoto Y; Yoshii T; Nakahara S; Hatazawa J; Inohara H
    Ann Nucl Med; 2013 Dec; 27(10):880-5. PubMed ID: 23979967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Linz C; Brands RC; Hackenberg S; Hartmann S; Iring T; Hohm J; Haug L; Kertels O; Kircher M; Dierks A; Buck AK; Brumberg J; Lapa C
    J Craniomaxillofac Surg; 2022 Aug; 50(8):671-676. PubMed ID: 35794029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest radiography or chest CT plus head and neck CT versus
    Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors.
    Garcheva M; Zlatareva D; Gocheva L
    Klin Onkol; 2014; 27(4):283-6. PubMed ID: 25115718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
    Chen SH; Chan SC; Chao YK; Yen TC
    PLoS One; 2013; 8(11):e82812. PubMed ID: 24312435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.
    Kostakoglu L; Fardanesh R; Posner M; Som P; Rao S; Park E; Doucette J; Stein EG; Gupta V; Misiukiewicz K; Genden E
    Oncologist; 2013; 18(10):1108-17. PubMed ID: 24037978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
    Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.
    Derlin T; Clauditz TS; Quaas A; Habermann CR
    Clin Nucl Med; 2012 Oct; 37(10):e255-6. PubMed ID: 22899191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.
    Ilcheva M; Nikolova P; Hadzhiyska V; Mladenov K
    Neoplasma; 2022 Jul; 69(4):948-956. PubMed ID: 35471980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
    Stokkel MP; Moons KG; ten Broek FW; van Rijk PP; Hordijk GJ
    Cancer; 1999 Dec; 86(11):2370-7. PubMed ID: 10590380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
    Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY
    J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.